Furthermore, regulating FGF15/19 affects carbohydrate and lipid metabolism, including TG concentrations, insulin sensitivity, weight loss, and obesity-associated hyperlipidemia [49]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.